Rheumatologic manifestations of chronic graft vs host disease. 4 case reports
García López, A.; Parody Ruiz-Verdejo, R.; de la Iglesia Salgado, J.L.; Povedano Gómez, J.; Albornoz López, J.
Revista Clinica Espanola 199(11): 722-724
1999
ISSN/ISBN: 0014-2565 PMID: 10638236 Document Number: 511505
A description is given of four patients with the diagnosis of chronic graft-versus-host disease (cGVHD) who developed articular manifestations during the clinical course. One of the patients developed advanced lesions of scleroderma. The rheumatologic changes of the disease as well as other affections of organs, complications and prophylaxis are reviewed.
Document emailed within 1 workday
Related Documents
Thorn, J.J.; Schiødt, M.; Jacobsen, N. 1987: Oral manifestations in chronic graft-versus-host disease Ugeskrift for Laeger 149(10): 648-651Deeg, H.J.; Storb, R. 1986: Acute and chronic graft-versus-host disease: clinical manifestations, prophylaxis, and treatment Journal of the National Cancer Institute 76(6): 1325-1328
Atkinson, K.; Downs, K. 1995: Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation Bone Marrow Transplantation 16(6): 755-758
Via, C.S.; Rus, V.; Gately, M.K.; Finkelman, F.D. 1994: IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease Journal of Immunology 153(9): 4040-4047
Rodu, B.; Gockerman, J.P. 1983: Oral manifestations of the chronic graft-v-host reaction JAMA 249(4): 504-507
Mixon, B.; Mixon, J.; Isbey, E.K.; Sprinkle, S. 2014: Autologous serum eye drops for severe dry eye syndrome in a patient with chronic graft-versus-host disease: a case report International Journal of Pharmaceutical Compounding 18(5): 370-377
Ushiyama, C.; Hirano, T.; Miyajima, H.; Okumura, K.; Ovary, Z.; Hashimoto, H. 1995: Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease Journal of Immunology 154(6): 2687-2696
Atkinson, K.; Storb, R.; Weiden, P.L.; Deeg, H.J.; Gerhard-Miller, L.; Thomas, E.D. 1980: In vitro tests correlating with presence or absence of graft-vs-host disease in DLA nonidentical canine radiation chimeras: evidence that clonal abortion maintains stable graft-host tolerance Journal of Immunology 124(4): 1808-1814
Atkinson, K. 1990: Chronic graft-versus-host disease Bone Marrow Transplantation 5(2): 69-82
Kolb, H.J.; Wundisch, G.F.; Bender, C.; Rodt, H.; Thiel, E.; Grosse-Wilde, H.; Thierfelder, S. 1978: Chronic graft-versus-host disease (GVHD) Pathologie-Biologie 26(1): 52
Holmes, J.A.; Livesey, S.J.; Bedwell, A.E.; Amos, N.; Whittaker, J.A. 1989: Autoantibody analysis in chronic graft-versus-host disease Bone Marrow Transplantation 4(5): 529-531
Li, V.; Molina, L.; Michallet, M.; Hostein, J. 1992: Digestive manifestations of graft-versus-host disease (GVHD) in bone marrow transplantation, organ transplantation and transfusion Gastroenterologie Clinique et Biologique 16(1): 29-36
Marosi, C.; Budka, H.; Grimm, G.; Zeitlhofer, J.; Sluga, E.; Brunner, C.; Schneeweiss, B.; Volc, B.; Bettelheim, P.; Panzer, S. 1990: Fatal encephalitis in a patient with chronic graft-versus-host disease Bone Marrow Transplantation 6(1): 53-57
Ringdén, O.; Paulin, T.; Lönnqvist, B.; Nilsson, B. 1985: An analysis of factors predisposing to chronic graft-versus-host disease Experimental Hematology 13(10): 1062-1067
García Gala, J.M.; Ramírez Páyer, A.; Rayón, C.; Rodríguez Vicente, P.; Rosón, C.; Blanco, C. 1993: Chronic posttransfusion graft-vs-host disease in a patient with non-Hodgkin's lymphoma Sangre 38(6): 489-491
Boström, L.; Ringdén, O.; Sundberg, B.; Ljungman, P.; Linde, A.; Nilsson, B. 1989: Pretransplant herpes virus serology and chronic graft-versus-host disease Bone Marrow Transplantation 4(5): 547-552
Owsianowski, M.; Gollnick, H.; Siegert, W.; Schwerdtfeger, R.; Orfanos, C.E. 1994: Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis Bone Marrow Transplantation 14(5): 845-848
Champlin, R.; Jansen, J.; Ho, W.; Gajewski, J.; Nimer, S.; Lee, K.; Territo, M.; Winston, D.; Tricot, G.; Reichert, T. 1991: Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia Transplantation Proceedings 23(1 Pt 2): 1695-1696
Nair, V.; Sharma, A.; Ghosh, I.; Arora, S.; Sahai, K.; Dutta, V. 2005: Extensive chronic graft-versus-host disease of skin successfully treated with thalidomide Journal of the Association of Physicians of India 53: 988-990
Schwinghammer, T.L.; Bloom, E.J.; Rosenfeld, C.S.; Wilson, J.W.; Przepiorka, D.; Shadduck, R.K. 1995: High-dose cyclosporine and corticosteroids for prophylaxis of acute and chronic graft-versus-host disease Bone Marrow Transplantation 16(1): 147-154